英国成人万古霉素处方:是否应放弃谷浓度 dosing?
本文讨论万古霉素治疗药物监测(TDM)方法。2020年IDSA指南推荐基于24小时AUC/MIC给药,而非谷浓度。英国尚未跟进,但证据显示谷浓度法增加肾毒性风险,作者认为应改用AUC/MIC指导给药。
要点
- 万古霉素TDM对疗效和安全性至关重要
- 2020年IDSA指南推荐24小时AUC/MIC指导给药
- 谷浓度法增加肾毒性风险,英国应考虑改用AUC/MIC
核心结论
- 万古霉素谷浓度给药法可靠性受质疑,应转向24小时AUC/MIC指导给药以安全使用该药。
研究设计与样本
- 本文为综述/评论,未报告系统检索范围或样本量。
主要发现
- 2020年IDSA万古霉素指南更新明确不依赖谷浓度给药,推荐24小时AUC/MIC。
- 有大量证据显示谷浓度给药使患者肾毒性风险更高。
- 英国尚未跟进AUC/MIC给药建议。
关键数值与推荐
- 2020年IDSA指南推荐万古霉素给药基于24小时AUC/MIC。
临床怎么用
- 临床应优先采用24小时AUC/MIC指导万古霉素给药,而非谷浓度。
局限性
- 本文未报告具体研究数据、样本量或系统评价方法。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Vancomycin remains a useful agent in the infection doctor's toolkit, particularly for Staphylococcus aureus and MRSA infections. Therapeutic drug monitoring (TDM) is essential to maintain efficacy and avoid toxicity. Until recently, trough-based dosing has been the recommended method but in recent years the reliability of this has been questioned. The 2020 Infectious Diseases Society of America (IDSA) vancomycin guideline update has sent a clear message that trough-based dosing is not to be relied on, instead recommending dosing via 24 h AUC/MIC. The UK, however, has yet to follow suit in this, despite the wealth of evidence showing that trough-based dosing puts patients at higher risk of nephrotoxicity. Clearly, it is time to incorporate AUC/MIC-based dosing to utilize this effective antibiotic safely.
引用
- Heard F, Sehgal A. Vancomycin in adult prescribing: is it time to move on from trough-based dosing in the UK? J Antimicrob Chemother. 2021. PMID: 34324650. doi:10.1093/jac/dkab274
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。